Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/1/1995
1.
Phase III Study Comparing Current Diagnostic Modalities to the Radioimmunoguided Surgery System Using 125I-Labeled MOAB CC49 for Intra-Abdominal Metastatic or Recurrent Adenocarcinoma of the Colon and Rectum (Summary Last Modified 05/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
NEO-2-14
NCI-V94-0563
Last Modified:
5/1/1995
2.
Phase III Study Comparing Current Diagnostic Modalities to the Radioimmunoguided Surgery System Using 125I-Labeled MOAB CC49 for Primary Adenocarcinoma of the Colon and Rectum (Summary Last Modified 05/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
NEO-2-13
NCI-V94-0567
Last Modified:
12/1/1998
 
First Published:
7/1/1998
3.
Phase I/II Study of Radioimmunoguided Surgery/Activated Cellular Therapy (RIGS/ACT) Following Complete Surgical Resection of Intraabdominal Disease in Patients with Recurrent Colorectal Cancer (Summary Last Modified 12/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
NEO-2-61
Last Modified:
3/1/1995
4.
Phase I Study of 90Y-MOAB CC49 for Unresectable or Metastatic Adenocarcinoma of the Gastrointestinal Tract (Summary Last Modified 03/95)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 to 65
NCI
UNMC-04194
NCI-B92-0019, B92-0019
Last Modified:
1/1/2000
5.
Phase I Study of 90Y-Labeled MOAB CC-49 plus Interferon Alfa with and without EDTA and DTPA in Patients with Advanced Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Completed
over 18
NCI
UAB-9445
NCI-B95-0004, B95-0004
Last Modified:
10/1/1900
6.
Phase IA/IB Study of Interferon Gamma plus 90Y-Labeled Monoclonal Antibody CC-49 for Metastatic or Unresectable Gastrointestinal Adenocarcinomas (Summary Last Modified 10/00)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
19 to 70
NCI
UNMC-11796
NCI-B95-0006, B95-0006
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute